BofA raised the firm’s price target on Amgen (AMGN) to $275 from $256 and keeps an Underperform rating on the shares. Q4 results were slightly ...
Pre-earnings options volume in Amgen (AMGN) is 2.2x normal with calls leading puts 9:4. Implied volatility suggests the market is anticipating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback